Physiatrist 发表于 2025-3-25 04:27:49

http://reply.papertrans.cn/83/8285/828449/828449_21.png

友好 发表于 2025-3-25 10:06:38

http://reply.papertrans.cn/83/8285/828449/828449_22.png

indecipherable 发表于 2025-3-25 15:15:25

http://reply.papertrans.cn/83/8285/828449/828449_23.png

使满足 发表于 2025-3-25 16:13:36

Alexey LarionovBrings together the current knowledge of molecular and translational aspects of AIs resistance in breast cancer.Provides mechanisms of physiological resistance and potential biomarkers that recognize

Offstage 发表于 2025-3-25 20:12:58

http://reply.papertrans.cn/83/8285/828449/828449_25.png

特别容易碎 发表于 2025-3-26 03:26:45

In Vivo Models of AI Resistance,front of breast cancer therapy. Now, these models are being exploited to develop strategies to overcome resistance to endocrine agents. Cell lines or tumor xenografts that are deprived of estrogen or treated extensively with aromatase inhibitors serve as models of breast cancers of patients that are receiving AIs in the clinical setting.

星球的光亮度 发表于 2025-3-26 07:12:13

http://reply.papertrans.cn/83/8285/828449/828449_27.png

Apoptosis 发表于 2025-3-26 10:22:23

http://reply.papertrans.cn/83/8285/828449/828449_28.png

BARGE 发表于 2025-3-26 16:30:37

Book 2015rehensive volume brings together the current knowledge from different relevant areas, including molecular mechanisms and translational aspects of drug resistance in AIs. Topics covered include research, experimental , and clinical data specifically focused on AI resistance in breast cancer. The volu

火车车轮 发表于 2025-3-26 17:06:41

http://reply.papertrans.cn/83/8285/828449/828449_30.png
页: 1 2 [3] 4 5
查看完整版本: Titlebook: Resistance to Aromatase Inhibitors in Breast Cancer; Alexey Larionov Book 2015 Springer International Publishing Switzerland 2015 aromatas